Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors

Explore clinical trials studying Neuroectodermal Tumors. Study availability and eligibility vary by location and protocol.

6,008 public trials 1,220 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors trial results

Completed

Collecting and Storing Tissue From Young Patients With Cancer

NCT00898755

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Central Nervous System Neoplasm, +47 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

SRK-181 Alone or in Combination With Anti-PD-(L)1 Antibody Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (DRAGON)

NCT04291079

Conditions
Bronchial Neoplasms, Cancer, Carcinoma, +27 more
Locations
  • St. Jude Crosson Cancer Institute Fullerton, California, United States
  • University of California - San Diego La Jolla, California, United States
  • The Oncology Institute Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
View all 22 locations
View Trial Details
Completed

Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes

NCT03551626

Conditions
Body Temperature Changes, Fever, Malignant Melanoma, +14 more
Locations
  • Novartis Investigative Site Rosario, Sante Fe, Argentina
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Córdoba, Argentina
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
View all 100 locations
View Trial Details
Completed

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

NCT02388906

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0036 Little Rock, Arkansas, United States
  • Local Institution - 0117 La Jolla, California, United States
  • Local Institution - 0189 Los Angeles, California, United States
  • Local Institution - 0021 San Francisco, California, United States
View all 136 locations
View Trial Details
Completed

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

NCT04704154

Conditions
Astrocytoma, Carcinoma, Carcinoma, Squamous Cell, +21 more
Locations
  • City of Hope - Duarte Cancer Center Duarte, California, United States
  • Rocky Mountain Cancer Centers / Aurora, CO Aurora, Colorado, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Sarah Cannon Cancer Center Nashville, Tennessee, United States
View all 34 locations
View Trial Details

Related conditions